↓ Skip to main content

Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour

Overview of attention for article published in Cochrane database of systematic reviews, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
f1000
1 research highlight platform

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
74 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour
Published in
Cochrane database of systematic reviews, January 2013
DOI 10.1002/14651858.cd005196.pub4
Pubmed ID
Authors

Linyu Deng, Jing Zhang, Taixiang Wu, Theresa A Lawrie

Abstract

This is an update of the original review that was published in The Cochrane Database of Systematic Reviews, 2009, Issue 2. Gestational trophoblastic neoplasia (GTN) are malignant disorders of the placenta that include invasive hydatidiform mole, choriocarcinoma, placental-site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). Choriocarcinoma and invasive hydatidiform mole respond well to chemotherapy: low-risk tumours are treated with single-agent chemotherapy (e.g. methotrexate or actinomycin D), whereas high-risk tumours are treated with combination chemotherapy (e.g. EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine)). Various drug combinations may be used for high-risk tumours; however, the comparative efficacy and safety of these regimens is not clear.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 74 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 1%
Canada 1 1%
Unknown 72 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 22%
Student > Bachelor 12 16%
Researcher 10 14%
Unspecified 7 9%
Student > Postgraduate 7 9%
Other 22 30%
Readers by discipline Count As %
Medicine and Dentistry 46 62%
Unspecified 10 14%
Psychology 5 7%
Social Sciences 3 4%
Nursing and Health Professions 3 4%
Other 7 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2013.
All research outputs
#7,230,407
of 12,527,219 outputs
Outputs from Cochrane database of systematic reviews
#7,403
of 8,923 outputs
Outputs of similar age
#66,915
of 142,235 outputs
Outputs of similar age from Cochrane database of systematic reviews
#73
of 98 outputs
Altmetric has tracked 12,527,219 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 142,235 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.